Oxidative Medicine and Cellular Longevity / 2017 / Article / Tab 3

Research Article

Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis

Table 3

Short- and long-term outcome after aSAH.

Comparison groupsN
Total (group A + B)
Odds ratio for poor outcome
Group A/B
ZHeterogeneity
Group AGroup BChi2dfI2

Short-term outcome
Hp2-2Hp1-1192 (132 + 60)2.37 (1.12, 5.04)2.260.023.93324%
Hp1-1Hp2-1228 (168 + 60)1.53 (0.74, 3.14)1.160.255.92432%
Hp2-2Hp2-1300 (132 + 168)1.73 (1.02, 2.93)2.030.041.0440%
Hp2-2Hp1-1 + Hp2-1360 (132 + 228)2.07 (1.26, 3.41)2.870.0041.7740%
Hp2-1 + Hp2-2Hp1-1360 (300 + 60)1.50 (0.80, 2.82)1.260.215.78431%
Long-term outcome
Hp2-2Hp1-1216 (155 + 61)0.62 (0.32, 1.23)1.370.174.96260%
Hp1-1Hp2-1266 (205 + 61)0.78 (0.40, 1.53)0.720.473.58244%
Hp2-2Hp2-1360 (155 + 205)0.75 (0.48, 1.17)1.270.200.5520%
Hp2-2Hp1-1 + Hp2-1421 (155 + 266)0.73 (0.48, 1.12)1.440.151.5520%
Hp2-1 + Hp2-2Hp1-1421 (360 + 61)0.71 (0.38, 1.34)1.060.294.26253%

Note: denotes ; Z: test for overall effect.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.